List of articles with "Chengdu"

Kelun-Biotech's SKB103 Approval

Kelun-Biotech's SKB103 Approval

China Chengdu ADC Kelun-Biotech SKB103
Kelun-Biotech's 2025 Results

Kelun-Biotech's 2025 Results

China biopharmaceuticals Chengdu Kelun-Biotech ADCs
HBM9378 Phase I Results

HBM9378 Phase I Results

China Chengdu HBM9378 Harbour BioMed TSLP
Yamashita's New Venture

Yamashita's New Venture

China Chengdu elderly care Yamashita
NMPA Approves SKB575

NMPA Approves SKB575

China Chengdu Kelun-Biotech Harbour BioMed SKB575
Chengdu Lantern Fest

Chengdu Lantern Fest

China Chengdu AI Innovations Lantern Festival Chengdu Hi-Tech
Eforthink at MWC 2026

Eforthink at MWC 2026

China Chengdu UWB Eforthink Eforlink
Eforthink at MWC 2026

Eforthink at MWC 2026

China Chengdu UWB Eforthink MWC 2026
Eforthink Unveils UWB Tech

Eforthink Unveils UWB Tech

China Chengdu UWB Eforthink Eforlink
C-Ray's AAALAC Accreditation

C-Ray's AAALAC Accreditation

China Chengdu radiopharmaceuticals C-Ray Therapeutics AAALAC International
iRegene Hits Milestones

iRegene Hits Milestones

China Chengdu Parkinson's NouvNeu001 iRegene
ROSESELSA CAMBRIAN

ROSESELSA CAMBRIAN

China Chengdu Cambrian ROSESELSA Noise Cancelling
Sac-TMT Approval Milestone

Sac-TMT Approval Milestone

China Chengdu Kelun-Biotech sacituzumab tirumotecan HR+/HER2- Breast Cancer
UFC GYM® in China

UFC GYM® in China

China Chengdu fitness UFC GYM
Yutong's Growth 2025

Yutong's Growth 2025

China Electric Buses Chengdu Sustainable Transport Yutong Bus
Kelun-Biotech Approval

Kelun-Biotech Approval

China Chengdu Cancer Treatment Kelun-Biotech SKB105
Kelun-Biotech BTD for NSCLC

Kelun-Biotech BTD for NSCLC

China Chengdu Kelun-Biotech Pembrolizumab sacituzumab tirumotecan
Nasdaq Deficiency Notice

Nasdaq Deficiency Notice

China Chengdu HVAC systems WF International NASDAQ WXM
HitGen's Commitment

HitGen's Commitment

China Chengdu SBTi climate action HitGen
AI-Edge Revolution

AI-Edge Revolution

Japan Chengdu Inhand Networks AI Testing Solutions Healthcare 5G
Chengdu: Innovation Hub

Chengdu: Innovation Hub

China Innovation Chengdu Technology
Chengdu: Innovation Hub

Chengdu: Innovation Hub

China Innovation Chengdu Science Technology
Chengdu's Innovation Hub

Chengdu's Innovation Hub

Chengdu Innovation Hub Sichuan Province
Chengdu's Innovation Hub

Chengdu's Innovation Hub

China Chengdu Innovation Hub Sichuan Province
Chengdu's Innovation Hub

Chengdu's Innovation Hub

China Innovation Chengdu Five-Year Plan
Chengdu Innovation Hub

Chengdu Innovation Hub

China Chengdu Innovation Hub Five-Year Plan
Sacituzumab Success

Sacituzumab Success

China Chengdu Kelun-Biotech Sacituzumab Urothelial Carcinoma
Chengdu: Innovation Hub

Chengdu: Innovation Hub

Chengdu Innovation Hub Sichuan Province
Panda Carnival Gala 2025

Panda Carnival Gala 2025

China Chengdu Panda Carnival Chengdu Panda Conservation Gains
Kelun-Biotech's Lung Cancer Trial

Kelun-Biotech's Lung Cancer Trial

China Chengdu Kelun-Biotech KEYTRUDA Sac-TMT
New Funding for HitGen

New Funding for HitGen

China Chengdu Tuberculosis Malaria HitGen
WF International & Hisense

WF International & Hisense

China Chengdu WF International Hisense HVAC HVAC distribution
WF International Offering

WF International Offering

China Chengdu Public Offering HVAC systems WF International
WF International & HITACHI

WF International & HITACHI

China Chengdu HVAC systems Hitachi WF International
WF International Offering

WF International Offering

China Chengdu HVAC systems WF International NASDAQ WXM
OptiTROP-Lung04 Study

OptiTROP-Lung04 Study

China Chengdu Sacituzumab NSCLC EGFR-TKI
Cultural Tourism in Sichuan

Cultural Tourism in Sichuan

China Chengdu Panda Sichuan Ease Sichuan Tourism
Trastuzumab Botidotin Results

Trastuzumab Botidotin Results

China Chengdu Kelun-Biotech ESMO 2025 Trastuzumab Botidotin
Lung Cancer Breakthrough

Lung Cancer Breakthrough

China Chengdu Lung Cancer sacituzumab tirumotecan ESMO Congress
Sichuan Cultural Tourism

Sichuan Cultural Tourism

China Chengdu Cultural Tourism Chinese Heritage Sichuan Ease
Sichuan Cultural Tourism

Sichuan Cultural Tourism

China Chengdu Sichuan Ease Jiuzhaigou Valley Sichuan Opera
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan

China Chengdu Kelun-Biotech sacituzumab tirumotecan ESMO
Sichuan Tourism Logo Launch

Sichuan Tourism Logo Launch

China Chengdu Sichuan Cultural Tourism PANDAS
Sichuan Tourism Logo

Sichuan Tourism Logo

China Chengdu Panda Sichuan Ease Shu Culture
Trastuzumab Botidotin Approved

Trastuzumab Botidotin Approved

China Chengdu Kelun-Biotech Trastuzumab Botidotin HER2-Positive BC
Innovative Biomimetic Collagen

Innovative Biomimetic Collagen

China Chengdu Kyoto University LivingPhoenix Biomimetic Collagen
iRegene's Phase I Results

iRegene's Phase I Results

China Chengdu Therapeutics NouvNeu001 iRegene
C-Ray and Biokin Milestone

C-Ray and Biokin Milestone

China Chengdu C-Ray Therapeutics Biokin Pharmaceutical [177Lu]-BL-ARC001
Kelun-Biotech's Sac-TMT Approval

Kelun-Biotech's Sac-TMT Approval

China Chengdu Kelun-Biotech TROP2 ADC Sac-TMT
Full-Life Secures Funding

Full-Life Secures Funding

China Chengdu radiopharmaceuticals Full-Life Technologies Junson Capital

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.